Chen Schor is President & CEO of Adicet Bio, Inc.. Currently has a direct ownership of 138,471 shares of ACET, which is worth approximately $174,473. The most recent transaction as insider was on Jan 24, 2024, when has been sold 15,290 shares (Common Stock) at a price of $2.4 per share, resulting in proceeds of $36,696. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 138K
0% 3M change
9.94% 12M change
Total Value Held $174,473

Chen Schor Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2024
SELL
Payment of exercise price or tax liability
$36,696 $2.4 p/Share
15,290 Reduced 9.94%
138,471 Common Stock
Jan 24 2024
BUY
Grant, award, or other acquisition
-
70,300 Added 25.19%
208,771 Common Stock
Oct 02 2023
SELL
Payment of exercise price or tax liability
$31,794 $1.37 p/Share
23,208 Reduced 13.11%
153,761 Common Stock
Sep 29 2023
SELL
Open market or private sale
$7,480 $1.36 p/Share
5,500 Reduced 3.01%
176,969 Common Stock
Sep 28 2023
BUY
Open market or private purchase
$7,810 $1.42 p/Share
5,500 Added 2.93%
182,469 Common Stock
Jan 24 2023
BUY
Grant, award, or other acquisition
-
85,500 Added 32.58%
176,969 Common Stock
Nov 10 2022
SELL
Open market or private sale
$209,353 $21.03 p/Share
9,955 Reduced 9.82%
91,469 Common Stock
Oct 04 2022
SELL
Payment of exercise price or tax liability
$302,715 $14.22 p/Share
21,288 Reduced 17.35%
101,424 Common Stock
Aug 04 2022
SELL
Payment of exercise price or tax liability
$388,506 $18.25 p/Share
21,288 Reduced 14.78%
122,712 Common Stock
Aug 04 2022
BUY
Grant, award, or other acquisition
-
48,000 Added 25.0%
144,000 Common Stock
Jul 06 2022
SELL
Bona fide gift
-
53,424 Reduced 35.75%
96,000 Common Stock
Feb 14 2022
SELL
Payment of exercise price or tax liability
$303,780 $14.27 p/Share
21,288 Reduced 12.47%
149,424 Common Stock
Feb 14 2022
BUY
Grant, award, or other acquisition
-
48,000 Added 21.95%
170,712 Common Stock
Jan 28 2022
SELL
Payment of exercise price or tax liability
$248,857 $11.69 p/Share
21,288 Reduced 14.78%
122,712 Common Stock
Jan 28 2022
BUY
Grant, award, or other acquisition
-
48,000 Added 25.0%
144,000 Common Stock
Oct 01 2021
BUY
Grant, award, or other acquisition
-
240,000 Added 50.0%
240,000 Common Stock
Oct 23 2020
SELL
Payment of exercise price or tax liability
-
8,649 Reduced 10.66%
72,499 Common Stock

Also insider at

KPTI
Karyopharm Therapeutics Inc. Healthcare
CS

Chen Schor

President & CEO
Boston, MA

Track Institutional and Insider Activities on ACET

Follow Adicet Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACET shares.

Notify only if

Insider Trading

Get notified when an Adicet Bio, Inc. insider buys or sells ACET shares.

Notify only if

News

Receive news related to Adicet Bio, Inc.

Track Activities on ACET